DBV Technologies S.A. issued a press release regarding its BLA submission update for the VIASKIN® Peanut Patch for children aged 4 through 7 years. The company is working collaboratively with the FDA to optimize the review process in preparation for filing. DBV Technologies S.A. is a biotechnology company focused on developing medical treatments for peanut allergies.
